Selskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskaber - at drive handel med og tilbyde serviceydelser inden for sundhedsområdet samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 219.3 mio. | 29.2 mio. | 134.5 mio. | 111.2 mio. | 28 | |
CVR: 33161395
Secondary names: Specific Care A/S
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Kristine Sakstrup Haag joined the board
Henrik Kaastrup joined the board
Kristine Sakstrup Haag left the board
Henrik Kaastrup left the board
Companies in the same industry and area
CVR 43707795
CVR 33597037
CVR 40486585
CVR 33671245
CVR 40041796
The financial health of SPECIFIC PHARMA A/S appears robust, with a notable upward trajectory in both revenue and profit over the past few years. Revenue increased from 123.3 million DKK in 2022 to 219.3 million DKK in 2025, while profit rose significantly from 7.8 million DKK to 29.2 million DKK in the same period, indicating strong operational efficiency and market demand. The company's equity has also improved, reaching 111.2 million DKK, which reflects a solid capital position. However, the fluctuating profit margins and lack of a CDS score may raise concerns regarding financial stability. Overall, SPECIFIC PHARMA A/S is well-positioned within the pharmaceutical wholesale industry, demonstrating growth potential and increasing profitability.
AI-generated summary
companydata.dk